Using antibody-drug conjugates for anti-tumor immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using antibody-drug conjugates for anti-tumor immunity

Published:2024 Issue: Volume: Page:
ISSN:
Container-title:Reference Module in Life Sciences
language:en
Short-container-title:

Author:

Katrini Jalissa,Scafetta Roberta,Boldrini Laura,Ascione Liliana,Santoro Celeste,Guidi Lorenzo,Valenza Carmine,Trapani Dario,Curigliano Giuseppe

Publisher

Elsevier

Reference11 articles.

1. Predicting response to antibody drug conjugates: A focus on antigens’ targetability;Ascione;The Oncologist,2023

2. Drug-induced interstitial lung disease during cancer therapies: Expert opinion on diagnosis and treatment;Conte;ESMO Open,2022

3. Systemic therapy for HER2-positive metastatic breast cancer: Moving into a new era;Gion,2022

4. Resistance to antibody-drug conjugates targeting HER2 in breast cancer: Molecular landscape and future challenges;Guidi;Cancers,2023

5. Antibody–drug conjugates targeting HER2-mutant or HER2-(non) amplified solid tumors: is HER2 an agnostic target?;Guidi;Expert Opinion on Biological Therapy,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP